The anti-snoring devices market, projected to be valued at USD 1.72 Billion in 2025, is anticipated to grow steadily, reaching USD 2.82 Billion by 2032 at a CAGR of 7.3% during the forecast period. This growth is driven by the rising global prevalence of sleep-related disorders, particularly obstructive sleep apnea and habitual snoring, which are increasingly recognized as public health concerns. Growing awareness about the health risks associated with untreated snoring—such as cardiovascular complications and daytime fatigue—has led to the greater adoption of anti-snoring interventions. Technological advancements in device design, including smart wearable devices and custom-fit mandibular advancement devices, are further enhancing patient comfort and treatment adherence. Additionally, the increased availability of over-the-counter and online anti-snoring products is broadening consumer access, fueling sustained market growth.

Market Takeaways

• By Device Type, Mandibular Advancement Devices are projected to dominate the anti-snoring devices market with a 35.3% share in 2025. Their dominance is attributed to their clinically proven effectiveness in reducing snoring by repositioning the lower jaw, combined with user-friendly, custom-fit designs that enhance patient comfort and compliance.
• By Distribution Channel, Hospital and Retail Pharmacies are expected to account for the largest share of 45.8% in 2025. This is due to their broad accessibility, trusted dispensing environments, and increasing recommendation of anti-snoring devices by healthcare professionals for both diagnosed sleep apnea and habitual snoring cases.
• Regionally, North America is expected to lead the anti-snoring devices market in 2025, driven by the high awareness of sleep disorders, widespread use of sleep diagnostics, robust healthcare infrastructure, and the presence of leading device manufacturers offering technologically advanced and FDA-approved solutions.

Anti-Snoring Devices Market Report Coverage

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/anti-snoring-devices-market

Market Dynamics

The anti-snoring devices market is witnessing steady growth, driven by rising awareness of the health risks associated with untreated snoring and obstructive sleep apnea, including cardiovascular disease, metabolic disorders, and impaired cognitive function. As sleep disorders become more widely recognized across both developed and emerging economies, early diagnosis and proactive treatment are gaining momentum. The growing acceptance of non-invasive, user-friendly anti-snoring solutions—particularly mandibular advancement devices, tongue stabilizing devices, and positional therapy aids—is contributing significantly to increased market adoption.

In May 2022, Illusion Aligners, known for bringing revolutionary technologies to the dental industry, introduced a new Anti-Snoring Device (ASD). This oral anti-snoring device by Illusion Aligners is easy to wear, effective and is also comfortable. It can help experience undisturbed and restful sleep every night.

Moreover, the rise of telehealth platforms and e-commerce has expanded direct-to-consumer access to anti-snoring products, boosting sales in online and retail pharmacy channels. Simultaneously, favorable reimbursement policies in some countries and increased investment in sleep technology R&D are further propelling innovation. As consumer demand grows for compact, affordable, and personalized anti-snoring solutions, the market is poised for robust expansion in the coming years.

Market Trends

• Integration of Smart Technology and Connected Anti-Snoring Devices

The anti-snoring devices market is witnessing a shift toward smart, connected solutions that enable real-time monitoring and personalized adjustments to improve treatment efficacy. Devices equipped with sensors, mobile app connectivity, and AI-driven feedback systems are gaining popularity for offering a data-backed, user-centric approach to snoring management.

In January 2022, at CES 2022, 10minds unveiled the Motion Pillow 3, an AI-enhanced pillow featuring embedded acoustic sensors and mini air bags that detect snoring and gradually reposition the user's head to reduce airway obstruction. It connects to a companion app for sleep tracking and data-driven feedback.

• Growing Preference for Custom-Fit and Mandibular Advancement Devices

Demand is rising for custom-fitted mandibular advancement devices (MADs), which offer higher comfort, greater compliance, and superior clinical outcomes compared to generic or over-the-counter options. This trend is supported by increased collaboration between sleep clinics and dental practitioners to deliver personalized anti-snoring interventions.

In January 2024, the FDA granted 510(k) clearance to SnoreLessNow’s Anti-Snore Mouth Guard+ (SomniFit‑S in Europe), a Swiss-made, boil-and-bite mandibular advancement device (MAD) featuring a patented adjustment band for customizable comfort. It allowed talking and drinking while worn—bridging convenience and professional-grade fit—highlighting the industry's move toward higher-quality OTC solutions with dental principles behind them.

Market Opportunities

• Expansion into Underserved and Aging Global Markets

Anti-snoring devices remain significantly underutilized across many low- and middle-income countries (LMICs), despite the growing burden of sleep-disordered breathing (SDB), including snoring and obstructive sleep apnea (OSA). Key contributing factors include demographic shifts, lifestyle changes, and a growing prevalence of chronic comorbidities such as obesity, hypertension, type 2 diabetes, and cardiovascular disease—all of which are strongly linked to increased snoring severity and nighttime breathing disruptions.

Regions such as Southeast Asia, Latin America, the Middle East, and parts of Africa are experiencing rapid urbanization, sedentary lifestyles, and dietary transitions that have led to rising obesity rates and age-related sleep disorders. For instance, countries like India, Indonesia, Brazil, Mexico, and South Africa are witnessing both a surge in OSA incidence and an increase in sleep health awareness—yet diagnosis and treatment rates remain low due to limited access to sleep specialists, underdeveloped diagnostic infrastructure, and affordability barriers.

A 2023 review submitted in November 2024 and published in April 2025, by MDPI noted that up to 80% of individuals with moderate-to-severe OSA remain undiagnosed, underscoring the critical need for accessible screening and treatment in low-resource settings.

• Growth of E-Commerce and Direct-to-Consumer (DTC) Distribution Models

The rise of e-commerce platforms and direct-to-consumer (DTC) brands is reshaping how anti-snoring devices are marketed, purchased, and delivered globally. As consumers increasingly seek accessible, discreet, and home-based solutions for snoring, manufacturers are shifting toward online channels to expand market reach, improve brand visibility, and enhance consumer education.

The COVID-19 pandemic accelerated the adoption of online sleep health solutions, and this momentum continues as consumers favor the convenience of purchasing products such as mandibular advancement devices (MADs), nasal dilators, positional therapy aids, and smart anti-snoring wearables online, often without the need for clinical consultation. This has also created a strong market for subscription models, tele-sleep consultations, and at-home fitting kits that improve user experience and long-term compliance.

For instance, in March 2024, Smart Nora announced collaboration with Sunset Healthcare Solutions to enter the direct-to-consumer home medical equipment (DME) market in North America. The partnership aims to expand DTC reach by leveraging Sunset's distribution network, bringing their contact-free, AI-driven anti-snoring pillow system directly to consumers for at-home use—no clinical consultation required.

Analyst View

• The anti-snoring devices market is entering a transformative phase, driven by increasing public awareness of sleep health, the rising burden of untreated snoring and obstructive sleep apnea (OSA), and growing demand for user-friendly, non-invasive alternatives to traditional therapies like CPAP. As lifestyle-related disorders and aging populations continue to expand globally—particularly in Asia Pacific, Latin America, and the Middle East—the need for accessible, comfortable, and affordable snoring interventions is becoming more urgent.
• Technological innovation is reshaping the competitive landscape. The integration of smart sensors, AI-driven feedback, and mobile app connectivity into anti-snoring solutions is unlocking personalized therapy and improved adherence. Devices such as Motion Pillow 3 and SnoreLessNow’s FDA-cleared mouthguard reflect a broader shift toward digitally enhanced, data-backed snoring management solutions. This is expected to widen appeal across younger demographics and tech-savvy users who prioritize convenience, discretion, and remote monitoring.
• Direct-to-consumer (DTC) and e-commerce strategies are proving to be major growth accelerators. As patients increasingly seek over-the-counter and home-based treatments without requiring clinical visits, DTC brands are leveraging online platforms, sleep education, and subscription models to improve user access and engagement. Partnerships like that of Smart Nora and Sunset Healthcare exemplify how traditional DME channels are being hybridized with consumer-first delivery.
• Looking forward, the anti-snoring devices market is poised for robust growth through the convergence of sleep technology, dental innovation, and digital health platforms. Strategic collaborations between medical device manufacturers, dental practitioners, and telehealth providers will be key to expanding early screening and intervention efforts, particularly in underserved regions where diagnosis rates remain low. As reimbursement policies evolve and awareness deepens, the market is likely to shift toward a more preventive, lifestyle-integrated model of snoring and OSA management.

Recent Key Developments

• In July 2024, Snorles, a leading innovator in sleep technology, announced the launch of its latest product, GenioFlex. Snorles was created to address snoring issues and promote overall health and well-being. GenioFlex offers a fresh approach to managing snoring without the need for intrusive nighttime devices.
• In January 2023, Vivos Therapeutics, Inc., a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, announced a brand new clearance from the U.S. Food and Drug Administration (FDA) for its proprietary DNA appliance (daytime-nighttime appliance).

Competitive Landscape

• ResMed
• Koninklijke Philips NV
• SomnoMed
• Fisher & Paykel Healthcare Limited
• GSK plc.
• Apnea Sciences
• Meditas
• Evantis Inc.
• Rotech Healthcare
• The Pure Sleep Company
• Innovative Health Technologies
• Tomed GmbH
• Whole You Inc.
• AccuMED Corporation
• Vyaire Medical

Anti-Snoring Devices Market Segmentation

• By Device Type
• Mandibular Advancement Devices
• Tongue Stabilizing Devices
• Continuous Positive Airway Pressure (CPAP) Devices
• Others
• By Distribution Channel
• Hospital and Retail Pharmacies
• Online Pharmacies
• Others

Regional Insights

• North America
  • U.S.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe
  • Italy
  • Germany
  • U.K.
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • South Korea
  • India
  • Japan
  • China
  • Australia
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa